Economic evaluation of four follow-up strategies after curative treatment for breast cancer: Results of an RCT

Combining Individual-Level Discrete Choice Experiment Estimates and Costs to Inform Health Care Management Decisions about Customized Care: The Case of Follow-Up Strategies after Breast Cancer Treatment

“…Patients were found to have heterogeneous preferences for this type of care [24]. Individual preferences for breast cancer follow-up [24] and associated follow-up program-specific costs [25] were combined to illustrate how they can guide decisions on implementing customized care. The analysis is based on process-related aspects of follow-up (e.g., the frequency of follow-up visits and type of health care professional) and the costs associated with several follow-up strategies recently reported in the MaCare trial performed in The Netherlands.…”

Economic evaluations of follow-up strategies for cancer survivors: a systematic review and quality appraisal of the literature

“…Six studies [16,26,33,42,44,51] examined outcomes and costs of a variety of diagnostic tools (e.g., positron-emission tomography vs computed tomography) while four studies [14,23,38,41] related to cervical cancer compared human papilloma virus (HPV) test versus cytology as potential instruments to detect new lesions. Four studies [25,30,34,49] compared costs and health gains arising from a surveillance program versus a 'do nothing' strategy; 11 studies examined traditional hospital-based followup programs in comparison with programs led by other healthcare professionals (i.e., in eight cases [20,31,35,36,43,46,48,52] the nurse and in three [17,19,28] the family physician). One study [15] compared a mobile-app follow-up versus traditional in-person consultations and another one [24] described two programs with (and without) an educational session.…”

The future for follow-up of gynaecological cancer in Europe. Summary of available data and overview of ongoing trials

“…reported that nurse-led telephone follow-up for breast cancer patients represented savings for patients in terms of time and money but was more costly to the UK's National Health Service (NHS) as telephone calls were longer than hospital appointments and were made by senior nurses [56]. However, Kimman et al (2011) carried out an economic evaluation of four follow-up strategies after curative treatment for breast cancer in the Netherlands and concluded that nurse-led telephone follow-up was a cost effective alternative to hospital follow-up for breast cancer patients during their first year after treatment Revised submission position paper 31.12.16…”

“…Page 13 [57]. The economic evaluation conducted as part of the ENDCAT trial indicated that nurse-led telephone follow-up was cost neutral for the UK's NHS and patients saved time and money [58].…”